WHO ICTRP trial
BIC CNS Study
EUCTR2019-004007-12-GB · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2019-004007-12-GB |
|---|---|
| Public title | BIC CNS Study |
| Scientific title | Brain connectivity and patient reported outcomes in people with HIV (PWH) with symptoms of insomnia switching integrase inhibitor-based ART; a randomised controlled study - BIC CNS Study |
| Primary sponsor | University of Sussex |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | United Kingdom |
| Conditions | HIV infection;Therapeutic area: Diseases [C] - Virus Diseases [C02] |
| Interventions | Trade Name: Biktarvy Product Name: Biktarvy Pharmaceutical Form: Film-coated tablet INN or Proposed INN: bictegravir Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 50- INN or Proposed INN: emtricitabine… |
| Registration date | Feb 3, 2020 |
| Target size | 46 |
| Secondary IDs | 066VER |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: